Zepbound generates a lot of questions from people comparing their weight-loss options, particularly around what it actually is, where it is available, and how it stacks up against Ozempic and Mounjaro. Here are clear answers to some of the most common questions we hear.

Is Zepbound Available in the UK?

No. Zepbound is the brand name used only in the United States, where it is approved specifically for weight management. It is not marketed or licensed in the UK. UK patients looking for the same active ingredient are prescribed Mounjaro instead, which is available here for both weight management and type 2 diabetes.

Is Zepbound the Same as Ozempic?

No, they are different medicines. Zepbound’s active ingredient is tirzepatide, a dual GIP/GLP-1 receptor agonist made by Eli Lilly. Ozempic’s active ingredient is semaglutide, a GLP-1-only receptor agonist made by Novo Nordisk. Both are once-weekly injections and both affect appetite regulation, but they act on different receptor pathways and are not interchangeable.

How Is Zepbound Different From Mounjaro?

Zepbound and Mounjaro both contain tirzepatide and are made by the same manufacturer, so clinically they are the same drug. The difference comes down to branding and licensed use by market: in the US, Lilly markets tirzepatide as Mounjaro for type 2 diabetes and as Zepbound for weight management. In the UK and much of Europe, Mounjaro covers both indications under a single brand name, and there is no separate Zepbound product.

How Much Weight Can You Lose on Zepbound in 3 Months?

Results vary considerably from person to person, and three months is still relatively early in the dose-titration schedule, since most patients are only partway up from the 2.5 mg starting dose by that point. In the SURMOUNT-1 trial, the largest weight-loss results, in the region of 15 to 21% of body weight depending on the dose, were measured at 72 weeks rather than at 3 months. Early-stage loss by the 3-month mark tends to be more modest, often in the region of mid-to-high single-digit percentages of body weight, with more substantial results building over the following months as the dose is increased under medical supervision.

Considering Tirzepatide Treatment?

If you are weighing up your options between tirzepatide-based treatments, Metabolic Slim Clinic’s specialist doctors can assess your eligibility for Mounjaro, explain how it compares to other GLP-1 treatments, and set realistic expectations for your own weight-loss timeline based on your health history. Book a consultation with one of our doctors to find out more.